Role of hemodynamic forces in the ex vivo arterialization of human saphenous veins

被引:50
作者
Berard, Xavier [1 ]
Deglise, Sebastien [2 ]
Alonso, Florian [2 ]
Saucy, Francois [2 ]
Meda, Paolo [3 ]
Bordenave, Laurence [1 ]
Corpataux, Jean-Marc [2 ]
Haefliger, Jacques-Antoine [2 ]
机构
[1] Univ Bordeaux, Pellegrin Hosp, Dept Vasc Surg, Bordeaux, France
[2] Univ Lausanne Hosp, Dept Thorac & Vasc Surg, Expt Med Lab, Lausanne, Switzerland
[3] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland
基金
瑞士国家科学基金会;
关键词
PLASMINOGEN-ACTIVATOR INHIBITOR-1; INTIMAL HYPERPLASIA DEVELOPMENT; MATRIX METALLOPROTEINASES; CELLULAR PROLIFERATION; PULSATILE PERFUSION; TISSUE INHIBITOR; SHEAR-STRESS; INCREASES; GRAFTS; BYPASS;
D O I
10.1016/j.jvs.2012.09.041
中图分类号
R61 [外科手术学];
学科分类号
100210 [外科学];
摘要
Background: Human saphenous vein grafts are one of the salvage bypass conduits when endovascular procedures are not feasible or fail. Understanding the remodeling process that venous grafts undergo during exposure to arterial conditions is crucial to improve their patency, which is often compromised by intimal hyperplasia. The precise role of hemodynamic forces such as shear stress and arterial pressure in this remodeling is not fully characterized. The aim of this study was to determine the involvement of arterial shear stress and pressure on vein wall remodeling and to unravel the underlying molecular mechanisms. Methods: An ex vivo vein support system was modified for chronic (up to 1 week), pulsatile perfusion of human saphenous veins under controlled conditions that permitted the separate control of arterial shear stress and different arterial pressure (7 mm Hg or 70 mm Hg). Results: Veins perfused for 7 days under high pressure (70 mm Hg) underwent significant development of a neointima compared with veins exposed to low pressure (7 mm Hg). These structural changes were associated with altered expression of several molecular markers. Exposure to an arterial shear stress under low pressure increased the expression of matrix metalloproteinase (MMP)-2 and MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 at the transcript, protein, and activity levels. This increase was enhanced by high pressure, which also increased TIMP-2 protein expression despite decreased levels of the cognate transcript. In contrast, the expression of plasminogen activator inhibitor-1 increased with shear stress but was not modified by pressure. Levels of the venous marker Eph-B4 were decreased under arterial shear stress, and levels of the arterial marker Ephrin-B2 were downregulated under high-pressure conditions. Conclusions: This model is a valuable tool to identify the role of hemodynamic forces and to decipher the molecular mechanisms leading to failure of human saphenous vein grafts. Under ex vivo conditions, arterial perfusion is sufficient to activate the remodeling of human veins, a change that is associated with the loss of specific vein markers. Elevation of pressure generates intimal hyperplasia, even though veins do not acquire arterial markers. (J Vasc Surg 2013; 57: 1371-82.)
引用
收藏
页码:1371 / 1382
页数:12
相关论文
共 40 条
[1]
Loss of connexin40 is associated with decreased endothelium-dependent relaxations and eNOS levels in the mouse aorta [J].
Alonso, Florian ;
Boittin, Francois-Xavier ;
Beny, Jean-Louis ;
Haefliger, Jacques-Antoine .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2010, 299 (05) :H1365-H1373
[2]
An angiotensin II- and NF-κB-dependent mechanism increases connexin 43 in murine arteries targeted by renin-dependent hypertension [J].
Alonso, Florian ;
Krattinger, Nathalie ;
Mazzolai, Lucia ;
Simon, Alexander ;
Waeber, Gerard ;
Meda, Paolo ;
Haefliger, Jacques-Antoine .
CARDIOVASCULAR RESEARCH, 2010, 87 (01) :166-176
[3]
Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling [J].
Berceli, SA ;
Jiang, ZH ;
Klingman, NV ;
Pfahnl, CL ;
Abouhamze, ZS ;
Frase, CD ;
Schultz, GS ;
Ozaki, CK .
JOURNAL OF VASCULAR SURGERY, 2004, 39 (05) :1084-1090
[4]
PATHOPHYSIOLOGY OF VEIN GRAFT FAILURE - A REVIEW [J].
DAVIES, MG ;
HAGEN, PO .
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 1995, 9 (01) :7-18
[5]
Plasminogen activator inhibitor type I increases neointima formation in balloon-injured rat carotid arteries [J].
DeYoung, MB ;
Tom, C ;
Dichek, DA .
CIRCULATION, 2001, 104 (16) :1972-1977
[6]
The 'PAI-1 paradox' in vascular remodelling [J].
Diebold, Isabel ;
Kraicun, Damir ;
Bonello, Steve ;
Goerlach, Agnes .
THROMBOSIS AND HAEMOSTASIS, 2008, 100 (06) :984-991
[7]
DOBRIN PB, 1989, SURGERY, V105, P393
[8]
Pulsatile ex vivo perfusion of human saphenous vein grafts under controlled pressure conditions increases MMP-2 expression [J].
Dummler, Sara ;
Eichhorn, Stefan ;
Tesche, Christian ;
Schreiber, Ulrich ;
Voss, Bernhard ;
Deutsch, Marcus-Andre ;
Hauner, Hans ;
Lahm, Harald ;
Lange, Ruediger ;
Krane, Markus .
BIOMEDICAL ENGINEERING ONLINE, 2011, 10
[9]
A novel urokinase receptor-targeted inhibitor for plasmin and matrix metalloproteinases suppresses vein graft disease [J].
Eefting, Daniel ;
Seghers, Leonard ;
Grimbergen, Jos M. ;
de Vries, Margreet R. ;
de Boer, Hetty C. ;
Lardenoye, Jan-Willem H. P. ;
Jukema, J. Wouter ;
van Bockel, J. Hajo ;
Quax, Paul H. A. .
CARDIOVASCULAR RESEARCH, 2010, 88 (02) :367-375
[10]
Time course of cellular proliferation, intimal hyperplasia, and remodeling following angioplasty in monkeys with established atherosclerosis - A nonhuman primate model of restenosis [J].
Geary, RL ;
Williams, JK ;
Golden, D ;
Brown, DG ;
Benjamin, ME ;
Adams, MR .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1996, 16 (01) :34-43